UK TEL: +44 (0) 1234 780020 | USA TEL: +1 888 381 6870
EPIDEMICS
Rapid diagnostics are pivotal for successful epidemic containment.
EPIDEMICS
Rapid Diagnostics for epidemics are critical for the surveillance, containment and elimination of epidemics in the absence of a vaccine programme.
Since 2018, Global Access Diagnostics (GADx) has increased its focus on epidemics and neglected diseases, with support from the Gates Foundation, the Wellcome Trust, the UK government, and the Foundation for Innovative New Diagnostics (FIND).
By detecting outbreaks early, in settings where laboratory capacity is limited, we can support more precise and responsive public health measures and immunisation campaigns.
PRODUCTS FOR EPIDEMICS
Ebola
A rapid test to detect viral antigens early in a fingerprick sample of blood for deployment at the point-of-need.
Yellow Fever
Yellow Fever RDT is a rapid test to detect viral antigens early in a fingerprick sample of blood. By detecting outbreaks early, in settings where laboratory capacity is limited, we can support more precise and responsive public health measures and immunisation campaigns.
Measles
A rapid test to detect IgM antibodies in 10 minutes. With support from the WHO, we will scale access to the rapid test to support surveillance and reduce reliance on laboratory testing.
Rubella
A rapid test to detect IgM antibodies in 10 minutes. With support from the WHO, we will scale access to the rapid test to support surveillance and reduce reliance on laboratory testing.
WHO BENEFITS FROM GADx SERVICES
PUBLIC HEALTH INSTITUTIONS
Rapid detection of diseases of epidemic potential is a top priority for national and global public health institutions. We can help you develop and access the right tests for the diseases that threaten public health the most.
DONORS AND THE GLOBAL HEALTH COMMUNITY
Supporting countries to rapidly detect and respond to disease outbreaks protects health everywhere and strengthens national health security. We can work together to develop tests for the most urgent health threats.
COMMUNITIES AND PATIENTS
COVID has shown us how Rapid Diagnostic Tests (RDTs) can play a key role in reducing transmission. Together we can empower people and communities to reduce their risks of suffering from an epidemic by providing quality, affordable tools.
INQUIRY MADE EASY
CONTACT US
If you see a product that meets your goals to improve the health of your customers, just contact us using the form below.
EXPLORATORY
Whether it is a product in our development phase or a new product idea, we will help you explore options and outline how we can serve you best.
FINALISATION
We are flexible in meeting your needs, whether its though licensing, direct sales, a distribution or a development partnership, we can suit your business needs in a seamless process from start to finish.
